dexcom sts system (Dexcom Inc)
86
Structured Review
Dexcom Inc
dexcom sts system
Dexcom Sts System, supplied by Dexcom Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/dexcom+sts/dexcom+sts+system/us12525351-150-28-28
Average 86 stars, based on 1 article reviews
Dexcom Sts System, supplied by Dexcom Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/dexcom+sts/dexcom+sts+system/us12525351-150-28-28
Average 86 stars, based on 1 article reviews
dexcom sts system - by Bioz Stars,
2026-09
86/100 stars
Images
Related Articles
Blocking Assay:Article Title: Algorithm-Enabled, Personalized Glucose Management for Type 1 Diabetes at the Population Scale: Prospective Evaluation in Clinical Practice Article Snippet: The data sets had 168,723 patient days of included CGM readings collected with seven types of CGMs: Article Title: A Machine Learning Model for Week-Ahead Hypoglycemia Prediction From Continuous Glucose Monitoring Data. Article Snippet: Background: Remote patient monitoring (RPM) programs augment type 1 diabetes (T1D) care based on retrospective continuous glucose monitoring (CGM) data.. Few methods are available to estimate the likelihood of a patient experiencing clinically significant hypoglycemia within one week.. Methods: We developed a machine learning model to estimate the probability that a patient will experience a clinically significant hypoglycemic event, defined as CGM readings below 54 mg/dL for at least 15 consecutive minutes, within one week. Article Title: Past, Present, and Future of Continuous Glucose Monitors. Article Snippet: Global prevalence of diabetes, both type 1 (T1D) and type 2 (T2D) diabetes, continues to increase and is expected to reach beyond 700 million people by 2040.. Most of this increase in prevalence is in the emerging economies: Middle East, China, and India.. Similarly, the cost of caring for diabetes also has significantly increased in the past decade Unfortunately, social–economically disadvantaged individuals and minorities are not offered the same treatment options, and thus, have poor overall long-term health outcomes. Article Title: Continuous glucose monitoring devices: A brief presentation (Review) Article Snippet: For the first time, real-time, personal use devices (Medtronic Guardian RT and Dexcom STS) had a lifetime of three days. Article Title: The Official Journal of ATTD Advanced Technologies & Treatments for Diabetes CONFERENCE 27–30 April 2022 I BARCELONA & ONLINE Article Snippet: I still remember doing studies on the GlucoWatch and earlier versions of |
